NattoPharma

NattoPharma ASA, headquartered in Norway, is the global leader in vitamin K2 research and development, offering the only clinically validated K2 as MK-7 on the market: MenaQ7®. NattoPharma provides the most comprehensive portfolio of K2 products, including naturally fermented and synthetically produced options with various concentrations and solubilities that are identical to natural forms, as well as the industry's first Full Spectrum K2, which delivers MK-6, MK-7, and MK-9. The MenaQ7® solutions platform offers brand owners solutions enabling the use of vitamin K2 across a broader range of finished product formats and, under the guidance of NattoPharma’s R&D team experts, provides opportunities for formulation with multiple active ingredients.